Boston Scientific Corporation Revenue 2007–2025
Boston Scientific Corporation reported $20.07B of revenue for fiscal 2025. That was 19.9% higher than fiscal 2024. Compared with fiscal 2020, the change was +102.5%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $20.07B | +19.9% |
| FY 2024 | $16.75B | +17.6% |
| FY 2023 | $14.24B | +12.3% |
| FY 2022 | $12.68B | +6.7% |
| FY 2021 | $11.89B | +19.9% |
| FY 2020 | $9.91B | -7.7% |
| FY 2019 | $10.73B | +9.3% |
| FY 2018 | $9.82B | +8.6% |
| FY 2017 | $9.05B | -0.3% |
| FY 2016 | $9.08B | +12.5% |
| FY 2015 | $8.07B | +8.1% |
| FY 2014 | $7.46B | +5.5% |
| FY 2013 | $7.07B | +1.6% |
| FY 2012 | $6.96B | -8.7% |
| FY 2011 | $7.62B | -2.4% |
| FY 2010 | $7.81B | -4.7% |
| FY 2009 | $8.19B | +1.7% |
| FY 2008 | $8.05B | -3.7% |
| FY 2007 | $8.36B | — |
Source: Boston Scientific Corporation SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open BSX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Boston Scientific Corporation reported $20.07B of revenue for fiscal 2025. That was 19.9% higher than fiscal 2024. Compared with fiscal 2020, the change was +102.5%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Boston Scientific Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBoston Scientific Corporation — frequently asked questions
What is Boston Scientific Corporation's revenue?
Boston Scientific Corporation (BSX) reported revenue of $20.07B for fiscal year 2025, per its SEC filings.
How has Boston Scientific Corporation's revenue changed over time?
Between fiscal 2007 and 2025, BSX's revenue grew at roughly 5.0% per year (compound annual rate), from $8.36B to $20.07B.
Where does this data come from?
Figures are computed from Boston Scientific Corporation's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.